Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Q3 2022 Earnings Conference Call November 10, 2022 8:30 AM ET

Company Participants

Mike Beaulieu - Investor Relations

Rob Spignesi - Chief Executive Officer

Sean Wirtjes - Chief Financial Officer

Conference Call Participants

Dan Arias - Stifel

Rachel Vatnsdal - JPMorgan

Stephanie Yan - Cowen

Operator

Hello. My name is Lisa and I will be your conference operator today. At this time, I would like to welcome everyone to the Rapid Micro Biosystems Third Quarter 2022 Earnings Conference Call. [Operator Instructions] I would now like to turn the call over to Mr. Mike Beaulieu. Please go ahead, sir.

Mike Beaulieu

Good morning and thank you for joining the Rapid Micro Biosystems third quarter 2022 earnings call. Joining me on the call are Rob Spignesi, Chief Executive Officer; and Sean Wirtjes, Chief Financial Officer. Earlier today, we issued a press release announcing our third quarter financial results. A copy of the release is available on the company’s website at rapidmicrobio.com under Investors in the News & Events section.

Before we begin, I’d like to remind you that many statements made during this call may be considered forward-looking statements within the meaning of federal securities laws, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that relate to expectations or predictions of future events, results or performance are forward-looking statements, including, but not limited to, statements relating to Rapid Micro’s financial condition, anticipated year-end cash balance, cash runway and future revenue and system placements, expectations for our projected cost savings resulting from the organizational restructuring actions, expectations for business development and growth, the Board of Directors’ review of potential strategic alternatives, customer interest and adoption of the Growth Direct System, expectations for new – for our new RMBNucleus Mold Alarm and the potential impact of macroeconomic uncertainty and COVID-19 on Rapid Micro’s business.

Actual results may differ materially from those expressed or implied in the forward-looking statements due to a variety of factors. For a list and description of the risks and uncertainties associated with Rapid Micro’s business, please refer to the Risk Factors section of our Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 24, 2022, as such risk factors are updated in our subsequent filings with the SEC. We urge you to consider these factors and you should be aware that these statements should be considered estimates only and are not a guarantee of future performance.